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Abstract
Background: Insulin secretion is a complex and highly regulated process. It is well established that cytoplasmic calcium is a
key regulator of insulin secretion, but how elevated intracellular calcium triggers insulin granule exocytosis remains unclear,
and we have only begun to define the identities of proteins that are responsible for sensing calcium changes and for
transmitting the calcium signal to release machineries. Synaptotagmins are primarily expressed in brain and endocrine cells
and exhibit diverse calcium binding properties. Synaptotagmin-1, -2 and -9 are calcium sensors for fast neurotransmitter
release in respective brain regions, while synaptotagmin-7 is a positive regulator of calcium-dependent insulin release.
Unlike the three neuronal calcium sensors, whose deletion abolished fast neurotransmitter release, synaptotagmin-7
deletion resulted in only partial loss of calcium-dependent insulin secretion, thus suggesting that other calcium-sensors
must participate in the regulation of insulin secretion. Of the other synaptotagmin isoforms that are present in pancreatic
islets, the neuronal calcium sensor synaptotagmin-9 is expressed at the highest level after synaptotagmin-7.
Methodology/Principal Findings: In this study we tested whether synaptotagmin-9 participates in the regulation of
glucose-stimulated insulin release by using pancreas-specific synaptotagmin-9 knockout (p-S9X) mice. Deletion of
synaptotagmin-9 in the pancreas resulted in no changes in glucose homeostasis or body weight. Glucose tolerance, and
insulin secretion in vivo and from isolated islets were not affected in the p-S9X mice. Single-cell capacitance measurements
showed no difference in insulin granule exocytosis between p-S9X and control mice.
Conclusions: Thus, synaptotagmin-9, although a major calcium sensor in the brain, is not involved in the regulation of
glucose-stimulated insulin release from pancreatic b-cells.
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Introduction
Maintenance of glucose homeostasis requires adequate amount
and precise pattern of insulin secretion, which is tightly controlled
and regulated in response to blood glucose levels and neuroen-
docrine cues [1,2]. A failure in these mechanisms leads to
hyperglycemia and type 2 diabetes, or life-threatening hypoglyce-
mic conditions [1]. The basic cellular events in the excitation-
secretion coupling of pancreatic b-cells are relatively well
described, such as glucose uptake into b-cells and consequent
changes in ATP/ADP ratio, membrane ion channel dynamics,
and elevated cytoplasmic calcium as the trigger for insulin granule
exocytosis [1,2]. However, the precise mechanism and temporal
events from calcium elevation to insulin granule exocytosis remain
elusive, and we have just begun to define the proteins involved in
calcium sensing in insulin secretion regulation [3,4,5].
Synaptotagmins, a family of at least 15 proteins, are primarily
expressed in neurons and endocrine cells [4,6]. Due to sequence
variations at the Ca
2+-coordinating sites and the flanking residues,
only eight synaptotagmins bind Ca
2+, and they exhibit diverse
Ca
2+ binding properties [4,6]. Synaptotagmin-1, -2 and -9
regulate fast neurotransmitter release, and function as calcium
sensors for neurotransmission of their respective brain regions
[7,8,9]. These synaptotagmins have low calcium affinity and
therefore can respond within milliseconds at the active zone where
cytoplasmic calcium concentration is high (,10–40 mM) to trigger
synaptic vesicle (SV) exocytosis [4]. In contrast, exocytotic rate of
insulin granules and of large-dense core vesicles (LDCV) in
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although insulin granule exocytosis in b-cells and catecholamine
release from chromaffin cells can also be triggered by high calcium
concentrations [10,11]. Despite the apparent differences between
SV and LDCV exocytosis, the exocytotic machinery in neuronal
and endocrine cells shows remarkable similarities [4,12]. SNAREs
operate during membrane fusion in both systems [12,13] and
synaptotagmins also function as calcium sensors in excitable
endocrine cells [4,14].
In our previous study, we identified synaptotagmin-7 as a high
affinity calcium sensor in insulin secretion, and found that deletion
of synaptotagmin-7 resulted in ,40% reduction in calcium-
dependent insulin release [15], which indicates that other proteins
must be responsible for regulating the remaining 60% of insulin
secretion. Besides synaptotagmin-7, several other calcium-binding
synaptotagmin isoforms are present in pancreatic islets [15]. Of
these, mRNA level of the neuronal calcium sensor synaptotagmin-
9 is the highest after synaptotagmin-7 in pancreatic islets [15].
Since insulin release can be evoked by a wide range of calcium
concentrations, from submicromolar to tens of mM [11], it is
conceivable that the low affinity calcium sensor synaptotagmin-9
may regulate insulin secretion in response to high calcium
concentrations, in collaboration with synaptotagmin-7, which is
responsible for insulin release at low calcium concentrations.
To investigate whether synaptotagmin-9 functions as a calcium
sensor in glucose-stimulated insulin release, we generated
pancreas-specific synaptotagmin-9 KO (p-S9X) mice, and tested
the effects of synaptotagmin-9 deletion on glucose homeostasis,
and on insulin secretion in vivo and in pancreatic islets and
b-cells.
Methods
Animal Welfare
All experiments involving animals were reviewed and approved
by the Institutional Animal Care and Use Committee of A*STAR
(Agency for Science, Technology and Research) under IACUC
#080351 and #090428.
Generation of Pancreas-Specific Synaptotagmin-9 KO
Mice
Pancreas-specific synaptotagmin-9 KO mice (p-S9X) were
generated by crossing synaptotagmin-9
fl/fl mice containing Cre
transgene under pdx1 promoter (Pdx1-Cre) with synaptotagmin-
9
fl/fl mice. The Pdx1-Cre mouse line was a generous gift from Dr.
Doug Melton (Harvard University). Floxed synaptotagmin-9
(synaptotagmin-9
fl/fl) mice were described previously [9]. Litter-
mates with genotypes of synaptotagmin-9
fl/fl/Pdx1-Cre (p-S9X)
and synaptotagmin-9
fl/fl (control) were used in this study.
Genotyping was performed on tail DNA by PCR using the
following primers: 59-TGC TTC TGT CCG TTT GCC GGT-39
and 59-CTA AGT GCC TTC TCT ACA CCT-39 (PCR product
of 500 bp indicates the presence of Cre transgene); 59- GCG TGA
GAA AAC TCA CTG GAT G-39 and 59- GTC CAC TAG GGC
TAG CCC AGG-39 (PCR fragment of 200 bp and 1100 bp
indicate the presence of wild type and mutant allele, respectively);
59- GAG AGT GAT AGA GAA AGA CAC-39 and 59- GTT
GAG ATG TAA TGT ATA CCT ATG C-39 (PCR product of
200 bp indicates the presence of mutant allele).
For islet isolation, histological staining, electron microscopy and
qPCR, mice were sacrificed by cervical dislocation. Altogether, 60
control and 53 p-S9X mice were used. All mice used in this study
were bred and housed in our animal facility.
Measurements of Body Weight and Body Composition
Mice were fed ad libitum with free access to water. Body weight
in p-S9X and control mice was monitored between 4 and 15 weeks
of age. Body fat and lean mass was analyzed on 16 wk-old mice by
using Echo MRI (Echo Medical Systems) as previously described
[15].
Glucose Tolerance Tests and Blood Glucose
Measurements
Intraperitoneal glucose tolerance tests (IPGTT) was performed
as previously described [15]. Briefly, 12–14 wk-old mice were
fasted for 16–18 h with free access to water. Blood glucose levels
were tested before and at 15, 30, 60, 90 and 120 min after i.p.
injection of 20% D-glucose solution at 2 g/kg of body weight.
,4 ml of tail vein blood was taken at each time point, and blood
glucose levels were determined by using Accu-Chek Advantage
blood glucose meter (Roche Diagnostics).
Glucose-Stimulated Insulin Secretion in vivo and Plasma
Insulin Measurements
Insulin secretion in vivo was induced by i.p. injection of 20% D-
glucose solution at 2 g/kg of body weight on 12–14 wk-old mice
after overnight fasting. ,20 ml blood samples were collected from
tail vein at 3, 8, 15, 30 and 60 min after glucose injection. Blood
samples were mixed with 2 ml of 0.5 M EDTA on ice and
centrifuged at 10,0006g for 5 min for plasma collection. Plasma
insulin concentrations were determined by using Ultrasensitive
Mouse Insulin ELISA Kit (Mercodia, Sweden).
Histological Analysis and Electron Microscopy
For histological analysis, pancreata from 4 mice of each group
(p-S9X and control mice) were fixed in 10% formalin at 4uC for
24 h before paraffin embedding. Then 5 mm serial sections from
each sample were processed for routine histological study
(hematoxylin-eosin). For transmission electron microscopy, pan-
creatic samples from 4 mice of each group (p-S9X and control
mice) were fixed in 2.5% glutaraldehyde (Agar Scientific) and in
1% OsO4 in PBS (pH 7.4) at 4uC for 2 h each, dehydrated in
ethanol series and embedded in araldite epoxy resin (EMS).
Ultrathin (,90 nm) sections were stained with 2% uranyl acetate
(Analar) for 10 min and examined by using a JEOL JEM-1220
electron microscope (JEOL Asia Pte).
Islet Isolation and Insulin Measurements
Islets from p-S9X and control mice were isolated by liberase
digestion (0.25 mg/ml; Roche) and cultured overnight at
11.1 mM glucose in Advanced RPMI 1640 medium supplement-
ed with 10% heat-inactivated fetal bovine serum, 1% penicillin/
streptomycin, 2 mM GlutaMax and 15 mM Hepes, pH 7.4
(Invitrogen). Subsequent experimental handling was performed
with a Krebs-Ringer-Hepes medium (KRH) containing (in mM)
130 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, and 2.56 CaCl2,
supplemented with 1 mg/ml BSA and 3 mM D-glucose. The
medium was buffered with 20 mM Hepes and NaOH to pH 7.4
and equilibrated with ambient air. For estimation of islet insulin
content, islets were lysed by sonication in 200 ml of passive lysis
buffer (Promega) after incubation in KRH medium containing
3 mM glucose for 2 h. Insulin content in the buffer was measured
by using Mouse Insulin ELISA (Mercodia).
For analysis of islet secretory responses, batches of 5 similar-
sized islets from a single mouse were placed in a 40-mL flow
chamber under continuous perifusion (0.3 ml/min) with KRH
medium containing 3 mM glucose for 60 min at 37uC. The
Synaptotagmin-9 in Insulin Secretion
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30 min. Fractions of the medium were collected every 3 min,
starting at 6 min before stimulation. Insulin concentration in each
fraction was measured by using Mouse Insulin ELISA (Mercodia).
Ca
2+ Measurements
Calcium measurements were performed as described previously
[15]. Briefly, isolated and overnight-cultured islets were loaded
with 3 mM Fluo-4 in KRH buffer containing 3 mM glucose for
1 hour, then placed in a perifusion chamber on the stage of an
inverted microscope (Nikon Eclipse TE2000-U) and continuously
superfused with KRH buffer containing 3 mM glucose at 37uC.
Fluo-4 was excited at 488 nm by using a 175-watt xenon arc lamp,
and emitted signal was projected onto a CCD camera (CoolSNAP
HQ2, Photometrics) after passing through a 535DF35 band pass
optical filter (Omega Optical). Images were collected every 2 sec,
and fluorescence signals from individual cells were measured as a
function of time using Metafluor software (Molecular devices).
Fluo-4 images were acquired for 2 minutes in KRH buffer
containing 3 mM glucose, and a further 10 minutes after the
superfusion was switched to KRH buffer containing 20 mM
glucose. Lag-time for [Ca
2+]i rise was defined as the time from the
buffer switch (3 mM to 20 mM glucose) to the first value above
baseline average, which was calculated during the 2 minutes
before stimulation. Calcium rise was calculated as the difference
between the average basal value and highest peak value.
RNA Extraction and Quantitative RT-PCR
Total RNA was extracted from islets of p-S9X and control mice
with TRIzol reagent (Invitrogen) according to the manufacturer’s
instructions. RNA samples were first treated with DNase I
(Roche), and then reverse-transcribed with RevertAid (Fermentas).
Quantitative real time PCR was performed by using SYBR Green
chemistry and gene-specific primers on an Applied Biosystems
StepOnePlus real-time PCR system. Primers used for detecting
mouse synaptotagmin-9 (mus musculus synaptotagmin V) gene
expression were designed by using PerkinElmer’s Primer Express
Software (59-TAA GAC ACC TCC AGA CTC CA-39 and 59-
TCA CTT CCT GAA GAT GGA CT-39, accession number:
NM_016908). Cyclophilin was used as the internal standard to
determine relative mRNA levels between samples (59-TGG AGA
GCA CCA AGA CAG ACA-39 and 59-TGC CGG AGT CGA
CAA TGA T-39, accession number: NM_011149).
Electrophysiology Measurements
Electrophysiology measurements were carried out essentially as
previously described [16]. Briefly, Single b-cells were obtained by
digestion of isolated pancreatic islets with 0.025 mg/ml trypsin
[17], distributed on polylysine-coated cover glasses and cultured
for 24 hours as described for islets. Membrane capacitance was
recorded from single b-cells using standard whole-cell patch-clamp
technique [18]. Exocytosis was elicited by a 500 ms depolarizing
pulse from 270 to 0 mV. Single b-cells were identified by the
absence of the transient Na
+-current and the outward TEA-
resistant K
+-current when the cells were given a depolarization
pulse from 270 to 0 mV. Pipette resistance ranged between 3 and
5M V when pipettes were filled with intracellular solution
containing (in mM): 135 KCl, 10 NaCl, 1 MgCl2, and 3 MgATP,
5 Hepes (pH 7.2 with KOH). Extracellular solution contained (in
mM): 118 NaCl, 20 TEA-Cl (tetraethylammonium chloride), 5.6
KCl, 2.6 CaCl2, 1.2 MgCl2, 5 D-glucose, and 5 Hepes (pH 7.4,
with NaOH). Cells were stimulated at low frequency (,0.05 Hz)
to allow full recovery of exocytotic capacity between pulses.
Measurements were performed by using EPC10 plus patch clamp
amplifier and analyzed by using Patchmaster software. Exocytosis
was detected as changes in cell membrane capacitance (Cm),
which was estimated by the Lindau-Neher technique implement-
ing the ‘Sine+DC’ feature of the lock-in module [19]. The
amplitude of the sine wave was 10 mV and the frequency was set
at 1 kHz. All Cm measurements were performed at 30–32uC.
Statistical Analysis
Data are presented as means 6 SEM. Comparisons of data
from p-S9X and control mice were made by using Student’s two-
tailed t-test for independent data. The significance limit was set at
P,0.05.
Results
Generation of pancreas-specific synaptotagmin-9 KO (p-
S9X) mice
To investigate whether synaptotagmin-9 was involved in the
regulation of glucose homeostasis and insulin secretion, we
generated pancreas-specific synaptotagmin-9 KO mice by crossing
synaptotagmin-9
fl/fl with and without Pdx1-Cre transgene
(Figure 1A). P-S9X and littermate synaptotagmin-9
fl/fl (control)
mice were used in the experiments. Pdx1 promoter drove specific
expression of Cre recombinase in the pancreas, with no detectable
expression in other tissues, as further confirmed by the lack of Cre
recombination activity outside the pancreas in p-S9X mice
(Figure 1B). Under the Pdx1 promoter, Cre expression in the
pancreatic epithelium started at early embryonic stages, which
ensured efficient synaptotagmin-9 deletion in the pancreas
(Figure 1C).
Body weight, glucose and insulin levels
P-S9X mice were viable and fertile, and showed no differences
from synaptotagmin-9
fl/fl in their postnatal development, includ-
ing body weight gain and body composition (Figure S1A and S1B).
We compared synaptotagmin-9
fl/fl with wild type mice, and found
no difference in body weight, glucose tolerance and glucose levels
(data not shown), therefore, we used synaptotagmin-9
fl/fl as control
to p-S9X mice in subsequent experiments. P-S9X mice and their
control showed similar fasting glucose levels (4.460.1 and
4.460.1 mmol/l, N=27 and 25 for control and p-S9X,
respectively; NS) and fed glucose levels (9.060.3 and
9.960.5 mmol/l, N=13 and 15 for control and p-S9X,
respectively; NS). Fasting insulin levels were the same
(0.2360.003 and 0.2360.003 ng/ml, N=21 and 23 for control
and p-S9X, respectively; NS) and fed insulin levels were also
similar in control and p-S9X mice (0.7860.14 and 0.6460.14 ng/
ml, N=8 and 7 for control and p-S9X, respectively; NS). These
results indicate that pancreas-specific deletion of synaptotagmin-9
had no effect on glucose homeostasis in p-S9X mice.
Glucose tolerance test and acute insulin response
Deletion of synaptotagmin-7, a calcium sensor in insulin
secretion, resulted in glucose intolerance and impaired insulin
secretion in synaptotagmin-7 KO mice, even though the KO mice
exhibited normal resting and fed glucose levels [15]. To examine
whether p-S9X mice were also defective in response to glucose
overload, we performed glucose tolerance tests and measured
glucose-induced insulin secretion in vivo in p-S9X and control
mice. After i.p. glucose injection, blood glucose increase and
clearance were similar in p-S9X and control mice (Figure 2A).
Plasma insulin levels were determined at 3, 8, 15, 30 and 60
minutes after glucose injection. No difference was observed in
glucose-induced insulin secretion in vivo (Figure 2B), and the area
Synaptotagmin-9 in Insulin Secretion
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measurement period was the same in p-S9X and control mice
(Figure 2C). These data indicate that glucose-stimulated insulin
secretion in p-S9X mice was adequate to regulate glucose
homeostasis under glucose overload, similar to that in control
mice, and further support the notion that synaptotagmin-9 was not
involved in the regulation of glucose homeostasis.
Glucose-induced insulin release from isolated islets
The fact that p-S9X mice showed normal glucose tolerance and
glucose-induced insulin secretion in vivo argues against synapto-
tagmin-9 as a calcium sensor in insulin granule exocytosis. Since
synaptotagmin-9 was deleted during embryonic development, p-
S9X mice might have developed mechanisms to compensate for
defects in calcium-dependent insulin granule exocytosis, e.g.
increased insulin content or increased number of islets in b-cells,
and as such, we failed to detect impaired insulin secretion in vivo as
measured in tail vein blood. To directly examine insulin secretion,
we performed perifusion experiments on isolated pancreatic islets,
and measured insulin secretion in response to glucose stimulation
(Figure 3A). Basal insulin secretion at 3 mM glucose was the same
in p-S9X and control mouse islets. High glucose challenge
induced more than 15-fold enhancement in insulin secretion at 6
minutes in both p-S9X and control islets, representing the peak
amplitude of the first phase of glucose-stimulated insulin
secretion. Insulin levels in the fractions collected between 9 and
15 minutes gradually decreased, but continued to show sustained
elevation above basal levels until the end of stimulation,
corresponding to the second phase of insulin secretion. There
was no difference in peak amplitude or time course of insulin
release between p-S9X and control mouse islets. Consequently,
net insulin secretion during the first 15 minutes of stimulation
(first phase) and over the entire stimulation period was similar
between p-S9X and control islets (Figure 3B). Islet insulin content
was the same in control and p-S9X mouse islets (Figure 3C).
These results showed that deletion of synaptotagmin-9 had no
effects on the amount or kinetics of glucose-induced insulin
secretion in p-S9X mice.
Morphological and ultrastructural characterization
To examine the involvement of synaptotagmin-9 in the
regulation of islet development and maintenance, we tested
whether deletion of synaptotagmin-9 in the pancreas led to
changes in islet architecture. Histological analysis of the pancreas
showed no pathological signs in p-S9X mouse islets, and no
differences with regard to the number, size or shape of islets
between p-S9X and control mice (Figure 4A). Vascularization of
islets and cell morphology were similar as well. We then examined
pancreatic b-cell ultrastructure. Electron microscopy of pancreatic
islets showed no differences between p-S9X and control mice in
terms of the number and appearance of insulin granules and b-cell
ultrastructure in general (Figure 4B). These data demonstrate that
islet development and maintenance were not dependent on
synaptotagmin-9, and that there were no compensatory changes
in islet architecture or b-cell ultrastructure.
Glucose-induced calcium responses
As calcium is the triggering signal for insulin granule exocytosis,
alterations in glucose-induced calcium responses might have
compensated for the deletion of synaptotagmin-9. To test this,
we recorded intracellular calcium changes to high glucose
stimulation in isolated islets from p-S9X and control mice.
Glucose-induced Ca
2+ responses showed a similar pattern in p-
S9X and control mouse islets (Figure S2). Calcium rise (188639
vs. 249636 a.u. for control and p-S9X mouse islets, respectively;
N=23–26, NS) and lag time (8867 vs. 7467 s for control and p-
Figure 1. Generation of pancreas-specific synaptotagmin-9 KO
(p-S9X) mice.( A) Homologous recombination and cre excision
strategy for generating pancreas-specific synaptotagmin-9 KO mice.
Syt9
fl/fl (synaptotagmin-9
fl/fl) showing targeted exon 2 and flanking loxP
sites, p-S9X showing synaptotagmin-9 gene structure after exon 2
deletion by cre recombination. (B) Representative genotyping patterns
for p-S9X and Syt9
fl/fl mice. Note that deletion of exon 2 was only
observed in the pancreas of p-S9X. (C) Synaptotagmin-9 mRNA levels
were analyzed by quantitative real time PCR on total RNA extracted
from p-S9X and Syt9
fl/fl (ctrl.) mouse islets. Data are presented as means
6 SEM. N=4 mice for each genotype. P,0.01.
doi:10.1371/journal.pone.0015414.g001
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p-S9X and control mice.
Insulin granule exocytosis in individual b-cells
Considering that brain-specific deletion of synaptotagmin-9
resulted in specific loss of fast neurotransmitter release in neurons
[9], and that synaptotagmin-9 may function as a low-affinity
calcium sensor for fast insulin release, it is possible that we might
have missed the insulin secretion defects in p-S9X mice in the
perifusion experiments due to intrinsic limitation of low temporal
resolution of this type of measurements. To better resolve calcium-
dependent insulin release, we recorded capacitance changes in b-
cells, as a measure of insulin granule exocytosis, in response to
membrane depolarizations (Figure 5A). Isolated b-cells from p-
S9X and control mice showed the same capacitance increases
(Figure 5B), indicating that calcium-triggered insulin granule
exocytosis was indistinguishable between p-S9X and control
b-cells. These data exclude the involvement of synaptotagmin-9
in regulating insulin granule exocytosis.
Discussion
Insulin, along with several other hormones and neuropeptides,
is responsible for the proper maintenance of glucose homeostasis.
Due to its great physiological effects in regulating glucose
clearance from the blood, insulin secretion is tightly regulated.
Insulin granule exocytosis can be triggered by a wide range of
calcium concentrations [11]. Therefore calcium sensing in b-cells
is expected to be complex, and may involve more than one
calcium sensors with appropriate calcium affinity and cooperativ-
ity to respond to various intracellular calcium levels during a
stimulus or under different stimuli. By analogy to neurotransmitter
release, we hypothesized that insulin secretion is controlled by at
least two types of calcium sensors: a low affinity sensor responsible
Figure 2. Normal glucose tolerance and in vivo insulin secretion in p-S9X mice. (A) Intraperitoneal glucose tolerance test (IPGTT) in p-S9X
and control mice. p-S9X mice (filled circles, N=16) showed the same glucose increase and clearance as control mice (open circles, N=15). (B) Insulin
secretion in vivo induced by i.p. injection of glucose in p-S9X and control mice. Plasma insulin levels were determined in control (open circle, N=21)
and p-S9X mice (filled circle, N=21) after i.p. injection of glucose. (C) Area under curve for the insulin secretion curves in (B). Data are presented as
means 6 SEM. N=21 for each genotype group.
doi:10.1371/journal.pone.0015414.g002
Figure 3. Glucose-stimulated insulin secretion from p-S9X mouse islets showed the same pattern as in control mouse islets. (A)
Insulin secretion from batches of 5 similar-sized islets in perifusion experiments in response to 20 mM glucose (arrow). N=20 for control mouse islets
(open circles), and 16 for p-S9X mouse islets (filled circles). (B) Insulin secretion during the first 15 minutes of stimulation (first phase) and over the
entire stimulation period (total), calculated as sum of insulin levels in all fractions after baseline subtraction. (C) Insulin contents in isolated individual
pancreatic islets from p-S9X and control mice. Data are presented as means 6 SEM. N=14 for control (white bar) and 19 for p-S9X (grey bar).
doi:10.1371/journal.pone.0015414.g003
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insulin release at low calcium concentrations.
We earlier identified synaptotagmin-7 as a high affinity calcium
sensor for insulin secretion, whose deletion resulted in ,40%
reduction in insulin release [15]. In this study, we focused on
synaptotagmin-9, the second most highly expressed calcium-
binding synaptotagmin in pancreatic islets, and tested our
hypothesis that synaptotagmin-9 functions as a low affinity calcium
sensor in insulin granule exocytosis.
Pancreas-specific synaptotagmin-9 KO mice showed no
differences in body weight, glucose tolerance, or glucose-induced
insulin secretion in vivo and from isolated islets when compared to
control mice. Deletion of synaptotagmin-9 also had no effects on
pancreas development, islet insulin content, islet architecture
or b-cell ultrastructure. Furthermore, calcium-triggered insulin
granule exocytosis as detected by membrane capacitance
measurements was normal in the absence of synaptotagmin-9.
These results demonstrated that synaptotagmin-9 was not
involved in the regulation of glucose homeostasis in general, or
insulin secretion in particular. Although synaptotagmin-9 exhib-
ited proper calcium binding properties required for insulin
secretion, our study does not support our initial hypothesis that
Figure 4. p-S9X mice exhibit similar islet architecture and b-cell ultrastructure as their control mice. (A) Histological sections stained
with hematoxylin and eosin (H&E). Representative sections are shown for p-S9X and control islets. N=4 mice for each genotype. Scale bar=50 mm.
(B) Transmission electron micrographs showing b-cells of p-S9X and control pancreas. Scale bars=2 mm.
doi:10.1371/journal.pone.0015414.g004
Figure 5. Normal membrane capacitance measurements in p-S9X mouse b-cells. (A) Membrane capacitance was recorded in functionally
identified b-cells from p-S9X and control mice. Capacitance increase was elicited by 500 ms depolarizations from -70 to 0 mV. (B) Capacitance
increases shown as means 6 SEM. N=7 for control mouse b-cells (white bar) and 9 for p-S9X (grey bar).
doi:10.1371/journal.pone.0015414.g005
Synaptotagmin-9 in Insulin Secretion
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insulin granule exocytosis.
An earlier study showed insulin secretion was reduced by ,30%
in isolated rat islets with synaptotagmin-9 knockdown by
adenoviral infection [20]. The apparent discrepancy between this
and our present study may be due to our choice of the
experimental subjects, as the pattern of glucose-induced insulin
secretion is not identical in rat and mouse [21,22]. It is possible
that distinct patterns of calcium response in rat and mouse may
result in different calcium levels, and thus requiring different
calcium sensing proteins. The discrepancy could also be due to our
choice in deleting synaptotagmin-9: genetic knockout vs. adeno-
virus-mediated RNAi, which may have undesired off-target effects
[23].
The lack of effect by synaptotagmin-9 deletion in the pancreas
could be the result of functional compensation by another
synaptotagmin. We first generated synaptotagmin-7 and -9 double
KO (DKO) mice, and compared insulin secretion in the DKO,
synaptotagmin-7 KO and wild type control mice (refer to
Materials and Methods S1). Although both DKO and synapto-
tagmin-7 KO mice showed impaired insulin secretion when
compared with control mice, there was no further impairment in
insulin secretion in DKO mice than in synaptotagmin-7 KO mice
(Figure S3). In addition to synaptotagmin-7 and -9, which are
expressed at high levels in pancreatic islets, two other calcium-
binding synaptotagmins, synaptotagmin-3 and -5, are expressed at
moderate levels in the islets [15]. We evaluated the expression of
synaptotagmin-3, -5 and -7, but did not detect an upregulation of
these synaptotagmins in p-S9X mice (data not shown). These
results demonstrate that the lack of effect in insulin secretion by
synaptotagmin-9 deletion was unlikely due to functional compen-
sation, leading to the conclusion that synaptotagmin-9 is not a
regulator of insulin secretion.
Besides synaptotagmins, other C2-containing proteins may
participate in the regulation of insulin secretion. Previous studies
have shown a potential role of the calpain family in insulin
secretion [24,25], possibly through partial proteolysis of SNAP-25
for the first phase [5] and ICA512 proteolysis for the second phase
[26].
In conclusion, our results show that synaptotagmin-9 does not
regulate glucose homeostasis or glucose-stimulated insulin secre-
tion in mice. Our current efforts are focused on identifying the
remaining calcium sensors for calcium-dependent insulin secretion
beyond synaptotagmin-7.
Supporting Information
Materials and Methods S1)
Figure S1 P-S9X mice exhibited similar body weight
and body composition as their control mice. (A) Body
weight development of p-S9X and control mice. Body weights
were measured on these two groups of mice between the age of 4
and 15 weeks. (B) Body fat and lean content in p-S9X and control
mice were measured when the mice were 14–15 weeks old. Data
are presented as means 6 SEM. N=9 for control (white bar) and
4 for p-S9X (grey bar).  (EPS)
Figure S2 Normal calcium response in p-S9X mouse
islets. Representative calcium responses induced by a rise in
glucose concentration from 3 to 20 mM in control (red trace) and
p-S9X (black trace) mouse islets (N=23 and 26, respectively). P-
S9X and control islets showed similar calcium response pattern
with regard to timing of response (lag time) and amplitude of
calcium rise (see RESULTS section for mean values and SEM).
Figure S3 Comparison of insulin secretion in control,
synaptotagmin-7 KO and synaptotagmin-7/-9 DKO
mouse islets. Insulin secretion in response to 20 mM glucose
was measured in batches of 5 similar-sized islets during the first 15
minutes (A, first phase) and the second 15 minutes (B, second
phase). N=18, 39 and 28 for control (Ctrl., white bar),
synaptotagmin-7 KO (Syt7
2/2, grey bar) and synaptotagmin-7/
-9 DKO (DKO, black bar), respectively. Data are presented as
means 6 SEM. Statistics is indicated on the graph. NS: not
significant.    (EPS)
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